These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15582304)

  • 1. MIC quality control guidelines for doxycycline when testing gram-positive control strains by the reference methods.
    Ross JE; Jones RN;
    Diagn Microbiol Infect Dis; 2004 Dec; 50(4):295-7. PubMed ID: 15582304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters.
    Arhin FF; Tomfohrde K; Draghi DC; Aranza M; Parr TR; Sahm DF; Moeck G
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):92-5. PubMed ID: 18614315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods.
    Ross JE; Jones RN
    J Clin Microbiol; 2005 Dec; 43(12):6212-3. PubMed ID: 16333134
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):147-9. PubMed ID: 15183865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN; Fritsche TR; Sader HS; Stilwell MG
    Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of novel rifamycins against gram-positive clinical isolates.
    Murphy CK; Karginova E; Sahm D; Rothstein DM
    J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Hammer KA; Carson CF; Riley TV
    Int J Antimicrob Agents; 2008 Aug; 32(2):170-3. PubMed ID: 18571379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.
    Kowalski RP; Yates KA; Romanowski EG; Karenchak LM; Mah FS; Gordon YJ
    Ophthalmology; 2005 Nov; 112(11):1987. PubMed ID: 16183128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms.
    Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3956-8. PubMed ID: 17065631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.
    Ross JE; Mendes RE; Jones RN
    J Clin Microbiol; 2014 Sep; 52(9):3399-401. PubMed ID: 24920777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic-resistance in Italy: activity of the first year of the surveillance project AR-ISS].
    Boccia D; D'Ancona F; Salmaso S; Monaco M; Del Grosso M; D'Ambrosio F; Giannitelli S; Lana S; Fokas S; Pantosti A;
    Ann Ig; 2005; 17(2):95-110. PubMed ID: 16676730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):459-65. PubMed ID: 17240105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens.
    Jones RN; Stilwell MG; Wilson ML; Mendes RE
    Diagn Microbiol Infect Dis; 2013 May; 76(1):69-72. PubMed ID: 23490012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.